Cancer Research Targets EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zea, A. H.
Right arrow Articles by Ochoa, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zea, A. H.
Right arrow Articles by Ochoa, A. C.
[Cancer Research 65, 3044-3048, April 15, 2005]
© 2005 American Association for Cancer Research

Priority Reports

Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion

Arnold H. Zea1,2, Paulo C. Rodriguez1,3, Michael B. Atkins5, Claudia Hernandez1, Sabina Signoretti5, Jovanny Zabaleta1,4, David McDermott5, David Quiceno1, Amanda Youmans5, Anne O'Neill5, James Mier5 and Augusto C. Ochoa1,2,3

1 Stanley S. Scott Cancer Center, Departments of 2 Immunology and Microbiology, 3 Pediatrics, and 4 Pathology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; and 5 Renal Cancer Program, Dana-Farber/Harvard Cancer Center Boston, Massachusetts

Requests for reprints: Augusto C. Ochoa, Stanley Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112. Phone: 504-599-0914; Fax: 504-599-0864; E-mail: aochoa{at}lsuhsc.edu.

Myeloid suppressor cells with high arginase activity are found in tumors and spleen of mice with colon and lung cancer. These cells, described as macrophages or immature dendritic cells, deplete arginine and impair T cell proliferation and cytokine production. Although arginase activity has been described in cancer patients, it is thought to originate from tumor cells metabolizing arginine to ornithine needed to sustain rapid cell proliferation. The goal of this study was to determine whether myeloid suppressor cells producing high arginase existed in renal cell carcinoma patients. Peripheral blood mononuclear cells from 123 patients with metastatic renal cell carcinoma, prior to treatment, were found to have a significantly increased arginase activity. These patients had a markedly decreased cytokine production and expressed low levels of T cell receptor CD3{zeta} chain. Cell separation studies showed that the increased arginase activity was limited to a specific subset of CD11b+, CD14–, CD15+ cells with a polymorphonuclear granulocyte morphology and markers, instead of macrophages or dendritic cells described in mouse models. Furthermore, these patients had low levels of arginine and high levels of ornithine in plasma. Depletion of the CD11b+, CD14– myeloid suppressor cells reestablished T cell proliferation and CD3{zeta} chain expression. These results showed, for the first time, the existence of suppressor myeloid cells producing arginase in human cancer patients. In addition, it supports the concept that blocking arginase may be an important step in the success of immunotherapy.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
S. Attig, J. Hennenlotter, G. Pawelec, G. Klein, S. D. Koch, H. Pircher, S. Feyerabend, D. Wernet, A. Stenzl, H.-G. Rammensee, et al.
Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas
Cancer Res., November 1, 2009; 69(21): 8412 - 8419.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Biswas, K. Biswas, A. Richmond, J. Ko, S. Ghosh, M. Simmons, P. Rayman, B. Rini, I. Gill, C. S. Tannenbaum, et al.
Elevated Levels of Select Gangliosides in T Cells from Renal Cell Carcinoma Patients Is Associated with T Cell Dysfunction
J. Immunol., October 15, 2009; 183(8): 5050 - 5058.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. K. Jensen, F. Donskov, N. Marcussen, M. Nordsmark, F. Lundbeck, and H. von der Maase
Presence of Intratumoral Neutrophils Is an Independent Prognostic Factor in Localized Renal Cell Carcinoma
J. Clin. Oncol., October 1, 2009; 27(28): 4709 - 4717.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. C. McKenna, K. M. Beatty, R. A. Bilonick, L. Schoenfield, K. L. Lathrop, and A. D. Singh
Activated CD11b+ CD15+ Granulocytes Increase in the Blood of Patients with Uveal Melanoma
Invest. Ophthalmol. Vis. Sci., September 1, 2009; 50(9): 4295 - 4303.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. J. Stewart, D. J. Liewehr, S. M. Steinberg, K. M. Greeneltch, and S. I. Abrams
Modulating the Expression of IFN Regulatory Factor 8 Alters the Protumorigenic Behavior of CD11b+Gr-1+ Myeloid Cells
J. Immunol., July 1, 2009; 183(1): 117 - 128.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
M. E. HANDEL-FERNANDEZ, D. ILKOVITCH, V. IRAGAVARAPU-CHARYULU, L. M. HERBERT, and D. M. LOPEZ
Decreased Levels of Both Stat1 and Stat3 in T Lymphocytes from Mice Bearing Mammary Tumors
Anticancer Res, June 1, 2009; 29(6): 2051 - 2058.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Mandruzzato, S. Solito, E. Falisi, S. Francescato, V. Chiarion-Sileni, S. Mocellin, A. Zanon, C. R. Rossi, D. Nitti, V. Bronte, et al.
IL4R{alpha}+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
J. Immunol., May 15, 2009; 182(10): 6562 - 6568.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Ilkovitch and D. M. Lopez
Urokinase-mediated recruitment of myeloid-derived suppressor cells and their suppressive mechanisms are blocked by MUC1/sec
Blood, May 7, 2009; 113(19): 4729 - 4739.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Oberlies, C. Watzl, T. Giese, C. Luckner, P. Kropf, I. Muller, A. D. Ho, and M. Munder
Regulation of NK Cell Function by Human Granulocyte Arginase
J. Immunol., May 1, 2009; 182(9): 5259 - 5267.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. A. Corzo, M. J. Cotter, P. Cheng, F. Cheng, S. Kusmartsev, E. Sotomayor, T. Padhya, T. V. McCaffrey, J. C. McCaffrey, and D. I. Gabrilovich
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
J. Immunol., May 1, 2009; 182(9): 5693 - 5701.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Ostrand-Rosenberg and P. Sinha
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
J. Immunol., April 15, 2009; 182(8): 4499 - 4506.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. S. Ko, A. H. Zea, B. I. Rini, J. L. Ireland, P. Elson, P. Cohen, A. Golshayan, P. A. Rayman, L. Wood, J. Garcia, et al.
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Clin. Cancer Res., March 15, 2009; 15(6): 2148 - 2157.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. C. Rodriguez, M. S. Ernstoff, C. Hernandez, M. Atkins, J. Zabaleta, R. Sierra, and A. C. Ochoa
Arginase I-Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
Cancer Res., February 15, 2009; 69(4): 1553 - 1560.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
B.-S. Choi, I. C. Martinez-Falero, C. Corset, M. Munder, M. Modolell, I. Muller, and P. Kropf
Differential impact of L-arginine deprivation on the activation and effector functions of T cells and macrophages
J. Leukoc. Biol., February 1, 2009; 85(2): 268 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Kusmartsev, Z. Su, A. Heiser, J. Dannull, E. Eruslanov, H. Kubler, D. Yancey, P. Dahm, and J. Vieweg
Reversal of Myeloid Cell-Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma
Clin. Cancer Res., December 15, 2008; 14(24): 8270 - 8278.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J.-I. Youn, S. Nagaraj, M. Collazo, and D. I. Gabrilovich
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
J. Immunol., October 15, 2008; 181(8): 5791 - 5802.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. H. Finke, B. Rini, J. Ireland, P. Rayman, A. Richmond, A. Golshayan, L. Wood, P. Elson, J. Garcia, R. Dreicer, et al.
Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
Clin. Cancer Res., October 15, 2008; 14(20): 6674 - 6682.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
P. Cheng, C. A. Corzo, N. Luetteke, B. Yu, S. Nagaraj, M. M. Bui, M. Ortiz, W. Nacken, C. Sorg, T. Vogl, et al.
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
J. Exp. Med., September 29, 2008; 205(10): 2235 - 2249.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. V. Novitskiy, S. Ryzhov, R. Zaynagetdinov, A. E. Goldstein, Y. Huang, O. Y. Tikhomirov, M. R. Blackburn, I. Biaggioni, D. P. Carbone, I. Feoktistov, et al.
Adenosine receptors in regulation of dendritic cell differentiation and function
Blood, September 1, 2008; 112(5): 1822 - 1831.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Kusmartsev, E. Eruslanov, H. Kubler, T. Tseng, Y. Sakai, Z. Su, S. Kaliberov, A. Heiser, C. Rosser, P. Dahm, et al.
Oxidative Stress Regulates Expression of VEGFR1 in Myeloid Cells: Link to Tumor-Induced Immune Suppression in Renal Cell Carcinoma
J. Immunol., July 1, 2008; 181(1): 346 - 353.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Movahedi, M. Guilliams, J. Van den Bossche, R. Van den Bergh, C. Gysemans, A. Beschin, P. De Baetselier, and J. A. Van Ginderachter
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
Blood, April 15, 2008; 111(8): 4233 - 4244.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. Negin, D. Panka, W. Wang, M. Siddiqui, N. Tawa, J. Mullen, S. Tahan, L. Mandato, A. Polivy, J. Mier, et al.
Effect of Melanoma on Immune Function in the Regional Lymph Node Basin
Clin. Cancer Res., February 1, 2008; 14(3): 654 - 659.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P.-Y. Pan, G. X. Wang, B. Yin, J. Ozao, T. Ku, C. M. Divino, and S.-H. Chen
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Blood, January 1, 2008; 111(1): 219 - 228.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Nefedova, M. Fishman, S. Sherman, X. Wang, A. A. Beg, and D. I. Gabrilovich
Mechanism of All-Trans Retinoic Acid Effect on Tumor-Associated Myeloid-Derived Suppressor Cells
Cancer Res., November 15, 2007; 67(22): 11021 - 11028.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. Badn, E. Visse, A. Darabi, K. E. Smith, L. G. Salford, and P. Siesjo
Postimmunization with IFN-{gamma}-Secreting Glioma Cells Combined with the Inducible Nitric Oxide Synthase Inhibitor Mercaptoethylguanidine Prolongs Survival of Rats with Intracerebral Tumors
J. Immunol., September 15, 2007; 179(6): 4231 - 4238.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. E. Talmadge
Pathways Mediating the Expansion and Immunosuppressive Activity of Myeloid-Derived Suppressor Cells and Their Relevance to Cancer Therapy
Clin. Cancer Res., September 15, 2007; 13(18): 5243 - 5248.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Lizee, M. A. Cantu, and P. Hwu
Less Yin, More Yang: Confronting the Barriers to Cancer Immunotherapy
Clin. Cancer Res., September 15, 2007; 13(18): 5250 - 5255.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. F. McDermott and M. B. Atkins
More Support for the Judicious Use of High-Dose Interleukin-2 in Patients With Advanced Melanoma
J. Clin. Oncol., September 1, 2007; 25(25): 3791 - 3793.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. Fricke, N. Mirza, J. Dupont, C. Lockhart, A. Jackson, J.-H. Lee, J. A. Sosman, and D. I. Gabrilovich
Vascular Endothelial Growth Factor-Trap Overcomes Defects in Dendritic Cell Differentiation but Does Not Improve Antigen-Specific Immune Responses
Clin. Cancer Res., August 15, 2007; 13(16): 4840 - 4848.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Sinha, V. K. Clements, S. K. Bunt, S. M. Albelda, and S. Ostrand-Rosenberg
Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response
J. Immunol., July 15, 2007; 179(2): 977 - 983.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. Filipazzi, R. Valenti, V. Huber, L. Pilla, P. Canese, M. Iero, C. Castelli, L. Mariani, G. Parmiani, and L. Rivoltini
Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor-Based Antitumor Vaccine
J. Clin. Oncol., June 20, 2007; 25(18): 2546 - 2553.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. M. Morris Jr.
Arginine Metabolism: Boundaries of Our Knowledge
J. Nutr., June 1, 2007; 137(6): 1602S - 1609S.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
P. J. Popovic, H. J. Zeh III, and J. B. Ochoa
Arginine and Immunity
J. Nutr., June 1, 2007; 137(6): 1681S - 1686S.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Barbey, P. Baumgaertner, E. Devevre, V. Rubio-Godoy, L. Derre, G. Bricard, P. Guillaume, I. F. Luescher, D. Lienard, J.-C. Cerottini, et al.
IL-12 Controls Cytotoxicity of a Novel Subset of Self-Antigen-Specific Human CD28+ Cytolytic T Cells
J. Immunol., March 15, 2007; 178(6): 3566 - 3574.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. C. Rodriguez, D. G. Quiceno, and A. C. Ochoa
L-arginine availability regulates T-lymphocyte cell-cycle progression
Blood, February 15, 2007; 109(4): 1568 - 1573.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G Parmiani, C Castelli, L Pilla, M Santinami, M. Colombo, and L Rivoltini
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
Ann. Onc., February 1, 2007; 18(2): 226 - 232.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. C. Ochoa, A. H. Zea, C. Hernandez, and P. C. Rodriguez
Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma
Clin. Cancer Res., January 15, 2007; 13(2): 721s - 726s.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Vieweg, Z. Su, P. Dahm, and S. Kusmartsev
Reversal of Tumor-Mediated Immunosuppression
Clin. Cancer Res., January 15, 2007; 13(2): 727s - 732s.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. I. Gabrilovich, V. Bronte, S.-H. Chen, M. P. Colombo, A. Ochoa, S. Ostrand-Rosenberg, and H. Schreiber
The Terminology Issue for Myeloid-Derived Suppressor Cells
Cancer Res., January 1, 2007; 67(1): 425 - 425.
[Full Text] [PDF]

Home page
 JEMHome page
P. Serafini, K. Meckel, M. Kelso, K. Noonan, J. Califano, W. Koch, L. Dolcetti, V. Bronte, and I. Borrello
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
J. Exp. Med., November 27, 2006; 203(12): 2691 - 2702.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Munder, H. Schneider, C. Luckner, T. Giese, C.-D. Langhans, J. M. Fuentes, P. Kropf, I. Mueller, A. Kolb, M. Modolell, et al.
Suppression of T-cell functions by human granulocyte arginase
Blood, September 1, 2006; 108(5): 1627 - 1634.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Lizee, L. G. Radvanyi, W. W. Overwijk, and P. Hwu
Improving Antitumor Immune Responses by Circumventing Immunoregulatory Cells and Mechanisms.
Clin. Cancer Res., August 15, 2006; 12(16): 4794 - 4803.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. C. McKenna and J. A. Kapp
Accumulation of Immunosuppressive CD11b+ Myeloid Cells Correlates with the Failure to Prevent Tumor Growth in the Anterior Chamber of the Eye
J. Immunol., August 1, 2006; 177(3): 1599 - 1608.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. A. Van Ginderachter, S. Meerschaut, Y. Liu, L. Brys, K. De Groeve, G. Hassanzadeh Ghassabeh, G. Raes, and P. De Baetselier
Peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer
Blood, July 15, 2006; 108(2): 525 - 535.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Lizee, L. G. Radvanyi, W. W. Overwijk, and P. Hwu
Immunosuppression in melanoma immunotherapy: potential opportunities for intervention.
Clin. Cancer Res., April 1, 2006; 12(7): 2359s - 2365s.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
P. C. Rodriguez, C. P. Hernandez, D. Quiceno, S. M. Dubinett, J. Zabaleta, J. B. Ochoa, J. Gilbert, and A. C. Ochoa
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
J. Exp. Med., October 3, 2005; 202(7): 931 - 939.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Suzuki, V. Kapoor, A. S. Jassar, L. R. Kaiser, and S. M. Albelda
Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity
Clin. Cancer Res., September 15, 2005; 11(18): 6713 - 6721.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Di Costanzo, G. Sabio, A. Mora, P. C. Rodriguez, A. C. Ochoa, F. Centeno, and D. W. Christianson
Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response
PNAS, September 13, 2005; 102(37): 13058 - 13063.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.